查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1447017

到 2030 年双室预充式註射器市场预测 - 按产品类型、类型、适应症、材料、配销通路、应用和地理位置进行的全球分析

Dual Chamber Prefilled Syringes Market Forecasts to 2030 - Global Analysis By Product Type, Type, Indication, Material, Distribution Channel, Application and by Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球双房预充式註射器市场规模为 1.6872 亿美元，预计到 2030 年将达到 3.0448 亿美元，预测期内复合CAGR为 8.8%。双室预充式註射器提供了一种简化的方法，可以轻鬆管理两种不同的物质，标誌着药物传输技术的重大进步。这些注射器上有两个隔间，里面有单独的组件或药物。由于该设计，药物可以单独储存并同时混合，从而在註射之前保持药物的效力和稳定性。此外，这种新方法在需要两种药物的组合才能达到给定治疗效果的情况下特别有用。

根据国际药用辅料理事会 (IPEC) 的说法，双室预充式註射器代表了药物传输技术的重大进步。这些注射器具有两个独立的室，通常设计用于储存和隔离不同的成分，例如药物和稀释剂。

市场动态：

司机：

提高药物稳定性

双室预充式註射器对于解决某些药物带来的稳定性问题至关重要。这些注射器在给药前将各个药物成分保持分开，从而避免过早混合，避免过早混合而导致降解。此外，这项功能对于容易出现物理或化学不稳定的药物尤其重要，因为它可以保证患者以最佳状态接受药物，从而改善治疗效果。

克制：

复杂的製造工序

双室预充式註射器有许多优点，但复杂的製造过程带来了一些困难。由于这些注射器的复杂构造和组装，生产成本可能会上升，这需要确保适当的零件隔离并保持整体结构完整性。此外，製造商必须解决这些复杂问题，以最大限度地提高生产效率和成本效益，这可能会影响双室预充式註射器的普遍使用。

机会：

特定药物配方的个体化

市场的一大机会是能够根据各种药物配方的独特需求订製双室预充式註射器。製造商和製药公司可以密切合作，生产专门设计用于满足各种药物需求的注射器。此外，这种个人化可以提高双室注射器对各种药物的适用性和效率，并鼓励製药业的合作和联盟。

威胁：

市场饱和与竞争环境

双室预灌封注射器市场存在竞争加剧和最终市场饱和的风险。随着更多製造商进入市场，过度饱和可能会导致价格战和利润率下降。此外，为了保持竞争力并有效应对潜在的市场饱和，公司需要透过创新、品质和策略​​合作伙伴关係来使其产品脱颖而出。

Covid-19 影响：

由于 COVID-19 大流行，双房预充式註射器市场既经历了机会，也面临挑战。一方面，由于全球各地对疫苗接种活动的日益关注，预充式註射器（包括双室型号）的需求量很大。这些注射器可为疫苗提供准确、高效的药物输送。但由于製造业停滞、全球供应链中断以及对医疗保健支出的审查加强，出现了一些困难。此外，大流行加速了新型药物输送解决方案的采用，并凸显了强大供应链的重要性。

预计糖尿病领域在预测期内将是最大的领域

在双室预充式註射器市场中，糖尿病市场预计将占据最大份额。全球糖尿病盛行率增加了对准确实用的给药系统的需求。具有两个腔室的预充式註射器对于需要在给药前混合胰岛素成分或重新配製药物的糖尿病患者特别有用。此外，这些注射器提供了更好的准确性，降低了剂量错误的可能性，并提高了患者对胰岛素时间表的依从性。

塑胶领域预计在预测期内复合CAGR最高

在双室预灌封注射器市场中，塑胶领域的CAGR最高。许多因素促成了这种成长。由于其固有的灵活性，塑胶预灌封注射器具有更好的抗破裂性、玻璃破碎机会更低和安全性更高等优点。此外，塑胶注射器更易于操作和携带。此外，众所周知，塑胶注射器比玻璃注射器便宜。该市场塑胶领域的强劲扩张归因于兽医、生物技术和製药等各种应用对双室预充式註射器的需求不断增长。

占比最大的地区：

在市场上，北美占据最大份额。由于各种因素，该领域的市场显着成长。北美因其成熟的生物技术和製药行业以及对尖端医疗技术和医疗保健基础设施的重视而引领该市场。此外，研发活动投资的增加以及对新型给药系统的强劲需求也有助于双室预充式註射器在该地区的采用。

复合CAGR最高的地区：

双室预灌封注射器市场的CAGR在亚太地区最高。许多因素对该地区的显着扩张发挥了作用。亚太地区经济的快速发展带来了更好的医疗基础设施和更高的医疗支出。因此，对复杂的药物输送装置（例如双室预充式註射器）的需求增加了。此外，人口老化、慢性病盛行率上升以及人们对预充式註射器优势的认识不断加深，都促进了该地区市场的扩张。

主要进展：

2024 年 2 月，全球领先的製药和生物技术公司拜耳 (BAYRY) 与科学数据和人工智慧云公司 TetraScience 宣布达成协议，旨在最大限度地发挥科学资料的价值并推动创新。此次合作将支持拜耳的使命，即提供下一代改变生活的疗法并确保全球粮食安全。

2023 年11 月，Gerresheimer 在墨西哥克雷塔罗的玻璃工厂举行了奠基仪式，庆祝其工厂扩建工程开工。这家製药和化妆品玻璃製造商将投资约1 亿欧元在位于墨西哥克雷塔罗的新建筑和新生产线建设。其克雷塔罗工厂。这将使其北美市场的注射器製造能力每年增加数亿支「即用型」(RTF) 注射器。

2023 年5 月，全球医疗保健技术领导者美敦力公司(Medtronic plc) 今天宣布，已签订一系列最终协议，收购EOPatch(R) 设备（一种无管、可穿戴和完全一次性胰岛素）的製造商EOFlow Co. Ltd.输送装置。 EOFlow 的加入，与美敦力(Medtronic) 的膳食检测技术(TM) 演算法和下一代连续血糖监测仪一起，预计将扩大该公司满足更多醣尿病患者需求的能力，无论他们处于治疗过程中的哪个阶段，还是在治疗过程中。他们希望如何输送胰岛素的偏好。

我们的报告提供了什么：

  • 区域和国家层面的市场份额评估
  • 对新进入者的策略建议
  • 涵盖2021年、2022年、2023年、2026年及2030年的市场资料
  • 市场趋势（驱动因素、限制因素、机会、威胁、挑战、投资机会和建议）
  • 根据市场预测提出关键业务部门的策略建议
  • 竞争性景观美化绘製主要共同趋势
  • 公司概况，包括详细的策略、财务状况和最新发展
  • 反映最新技术进步的供应链趋势

免费客製化产品：

本报告的所有客户都将有权获得以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 个）
    • 关键参与者的 SWOT 分析（最多 3 个）
  • 区域细分
    • 根据客户的兴趣对任何主要国家的市场估计、预测和CAGR（註：取决于可行性检查）
  • 竞争基准化分析
    • 根据产品组合、地理分布和策略联盟对主要参与者基准化分析

目录

第 1 章：执行摘要

第 2 章：前言

  • 抽象的
  • 股东
  • 研究范围
  • 研究方法论
    • 资料探勘
    • 数据分析
    • 数据验证
    • 研究方法
  • 研究来源
    • 主要研究来源
    • 二手研究来源
    • 假设

第 3 章：市场趋势分析

  • 介绍
  • 司机
  • 限制
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 新兴市场
  • Covid-19 的影响

第 4 章：波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争竞争

第 5 章：全球双房预灌封注射器市场：依产品类型

  • 介绍
  • 传统预灌封注射器
  • 安全预充式註射器
  • 其他产品类型

第 6 章：全球双房预灌封注射器市场：按类型

  • 介绍
  • <1毫升
  • 1毫升-2.5毫升
  • 2.5毫升-5.0毫升
  • >5.0 毫升
  • 其他类型

第 7 章：全球双房预灌封注射器市场：依适应症分类

  • 介绍
  • 血友病
  • 精神分裂症
  • 糖尿病
  • 性功能障碍
  • 子宫内膜异位症
  • 其他适应症

第 8 章：全球双房预灌封注射器市场：按材料

  • 介绍
  • 玻璃
  • 塑胶
  • 其他材料

第 9 章：全球双房预灌封注射器市场：按配销通路

  • 介绍
  • 医院药房
  • 零售药局
  • 网路药局

第 10 章：全球双房预灌封注射器市场：按应用

  • 介绍
  • 液体/粉末
  • 液体/液体
  • 液体/冷冻干燥物
  • 其他应用

第 11 章：全球双房预灌封注射器市场：依地理位置

  • 介绍
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太地区其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿联酋
    • 卡达
    • 南非
    • 中东和非洲其他地区

第 12 章：主要进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 扩充
  • 其他关键策略

第 13 章：公司概况

  • Gerresheimer AG
  • Medtronic
  • Bayer AG
  • Nipro Corporation
  • Elcam Drug Delivery Devices
  • Pfizer Inc.
  • Novartis AG
  • AbbVie Inc.
  • Mylan N.V.
  • Otsuka America Pharmaceutical, Inc.
  • Credence MedSystems Inc.
  • Vetter Pharma-Fertigung GmbH & Co. KG
  • Maeda Industry Co. Ltd.
  • Catalent, Inc.
  • Terumo Europe NV
  • West Pharmaceutical Services, Inc.
  • Schott AG
Product Code: SMRC25278

According to Stratistics MRC, the Global Dual Chamber Prefilled Syringes Market is accounted for $168.72 million in 2023 and is expected to reach $304.48 million by 2030 growing at a CAGR of 8.8% during the forecast period. Dual Chamber Prefilled syringes, which provide a simplified method for the easy administration of two different substances, mark a substantial advancement in drug delivery technology. There are two compartments on these syringes, and inside are separate components or medications. Drugs can be stored separately and mixed simultaneously thanks to the design, which maintains the drug's potency and stability until injection time. Moreover, this novel approach is especially useful in situations where the combination of two drugs is necessary for a given therapeutic effect.

According to the International Pharmaceutical Excipients Council (IPEC), dual chamber prefilled syringes represent a significant advancement in drug delivery technology. These syringes feature two separate chambers, typically designed to store and isolate different components, such as a drug and a diluent.

Market Dynamics:

Driver:

Improved medicine stability

Dual-chamber prefilled syringes are essential for resolving issues with stability that come with some medications. These syringes avoid premature mixing that can cause degradation by keeping individual drug components apart until the point of administration. Additionally, this feature is especially important for medications that are prone to physical or chemical instability because it guarantees that patients receive their medications in the best possible state, which improves therapeutic outcomes.

Restraint:

Intricate manufacturing procedures

Dual-chamber prefilled syringes have benefits, but complicated manufacturing procedures present some difficulties. Production costs may rise as a result of the complex construction and assembly of these syringes, which entails guaranteeing appropriate component isolation and upholding structural integrity overall. Furthermore, these intricacies must be resolved by manufacturers in order to maximize production efficiency and cost-effectiveness, which may have an effect on the general use of dual-chamber prefilled syringes.

Opportunity:

Individualization for particular drug formulations

One major opportunity to the market is the ability to tailor dual-chamber prefilled syringes to the unique needs of various drug formulations. Manufacturers and pharmaceutical companies can collaborate closely to create syringes that are specifically designed to meet the needs of various medications. Moreover, this personalization can improve dual chamber syringes' suitability and efficiency for a variety of medications, encouraging cooperation and alliances in the pharmaceutical sector.

Threat:

Market saturation and the competitive environment

There is a risk of growing competition and eventual market saturation in the dual-chamber prefilled syringe market. There's a chance that oversaturation will result in price wars and narrower profit margins as more manufacturers enter the market. Additionally, to remain competitive and effectively navigate potential market saturation, companies need to differentiate their products through innovation, quality, and strategic partnerships.

Covid-19 Impact:

The market for dual-chamber prefilled syringes has experienced both opportunities and challenges as a result of the COVID-19 pandemic. On the one hand, prefilled syringes, including dual chamber models, are in high demand due to the increased focus on vaccination campaigns around the globe. These syringes offer accurate and efficient drug delivery for vaccines. But there have been difficulties due to manufacturing hold-ups, disruptions in global supply chains, and increased scrutiny of healthcare spending. Furthermore, the pandemic has accelerated the adoption of novel drug delivery solutions and highlighted the significance of robust supply chains.

The Diabetes segment is expected to be the largest during the forecast period

In the market for dual-chamber prefilled syringes, the diabetes segment is predicted to hold the largest share. Global diabetes prevalence has increased demand for accurate and practical drug delivery systems. Prefilled syringes with two chambers are especially useful for diabetics who need to mix the components of insulin or reconstitute medications before administering them. Moreover, these syringes provide better accuracy, lower the possibility of dosage mistakes, and increase patient compliance with insulin schedules.

The Plastic segment is expected to have the highest CAGR during the forecast period

In the dual chamber prefilled syringe market, the plastic segment has shown the highest CAGR. Numerous factors contribute to this growth. Because of their inherent flexibility, plastic prefilled syringes have advantages like better break resistance, a lower chance of glass breaking, and increased safety. Additionally, plastic syringes are simpler to handle and carry. Furthermore, it's common knowledge that plastic syringes are less expensive than glass syringes. The strong expansion of the plastic segment in this market has been attributed to the growing need for dual chamber prefilled syringes in a variety of applications, including veterinary medicine, biotechnology, and pharmaceuticals.

Region with largest share:

In the market, North America holds the largest share. The market in this area has grown significantly as a result of various factors. North America leads this market because of its well-established biotechnology and pharmaceutical sectors, as well as its emphasis on cutting-edge medical technologies and healthcare infrastructure. Additionally, the adoption of dual-chamber prefilled syringes in the region has also been aided by increased investment in research and development activities and a strong demand for novel drug delivery systems.

Region with highest CAGR:

The dual chamber prefilled syringe market has shown the highest CAGR in the Asia-Pacific region. Numerous elements have played a role in the remarkable expansion of the area. Rapid economic development in the Asia-Pacific area has resulted in better healthcare infrastructure and higher healthcare spending. The need for sophisticated drug delivery devices, such as dual-chamber prefilled syringes, has therefore increased. Moreover, the aging population, increased prevalence of chronic illnesses, and growing knowledge of the advantages of prefilled syringes have all contributed to the region's market expansion.

Key players in the market

Some of the key players in Dual Chamber Prefilled Syringes market include Gerresheimer AG, Medtronic, Bayer AG, Nipro Corporation, Elcam Drug Delivery Devices, Pfizer Inc., Novartis AG, AbbVie Inc., Mylan N.V., Otsuka America Pharmaceutical, Inc., Credence MedSystems Inc., Vetter Pharma-Fertigung GmbH & Co. KG, Maeda Industry Co. Ltd., Catalent, Inc., Terumo Europe NV, West Pharmaceutical Services, Inc. and Schott AG.

Key Developments:

In February 2024, Bayer AG (BAYRY), a leading global pharmaceutical and biotechnology company, and TetraScience, the Scientific Data and AI Cloud company, announced an agreement aimed at maximizing the value of scientific data and driving innovation. This collaboration will support Bayer's mission to deliver the next generation of life-changing therapeutics and ensure global food security.

In November 2023, Gerresheimer held a groundbreaking ceremony at its glass facility in in Queretaro, Mexico to celebrate the start of construction for its plant expansion.The pharmaceutical and cosmetics glass manufacturer will invest approximately €100 million in a new building and new production lines at its Queretaro plant. This will increase its manufacturing capacity for syringes for the North American market by several hundred million "ready-to-fill" (RTF) syringes annually.

In May 2023, Medtronic plc, a global leader in healthcare technology, today announced it has entered into a set of definitive agreements to acquire EOFlow Co. Ltd., manufacturer of the EOPatch(R) device - a tubeless, wearable and fully disposable insulin delivery device. The addition of EOFlow, together with Medtronic's Meal Detection Technology(TM) algorithm and next-generation continuous glucose monitor, is expected to expand the company's ability to address the needs of more individuals with diabetes, no matter where they are in their treatment journey or preference for how they want their insulin delivered.

Product Types Covered:

  • Conventional Prefilled Syringes
  • Safety Prefilled Syringes
  • Other Product Types

Types Covered:

  • <1 ml
  • 1 ml-2.5 ml
  • 2.5 ml-5.0 ml
  • >5.0 ml
  • Other Types

Indications Covered:

  • Hemophilia
  • Schizophrenia
  • Diabetes
  • Erectile Dysfunction
  • Endometriosis
  • Other Indications

Materials Covered:

  • Glass
  • Plastic
  • Other Materials

Distribution Channels Covered:

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Applications Covered:

  • Liquid/Powder
  • Liquid/Liquid
  • Liquid/Lyophilisate
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Dual Chamber Prefilled Syringes Market, By Product Type

  • 5.1 Introduction
  • 5.2 Conventional Prefilled Syringes
  • 5.3 Safety Prefilled Syringes
  • 5.4 Other Product Types

6 Global Dual Chamber Prefilled Syringes Market, By Type

  • 6.1 Introduction
  • 6.2 <1 ml
  • 6.3 1 ml-2.5 ml
  • 6.4 2.5 ml-5.0 ml
  • 6.5 >5.0 ml
  • 6.6 Other Types

7 Global Dual Chamber Prefilled Syringes Market, By Indication

  • 7.1 Introduction
  • 7.2 Hemophilia
  • 7.3 Schizophrenia
  • 7.4 Diabetes
  • 7.5 Erectile Dysfunction
  • 7.6 Endometriosis
  • 7.7 Other Indications

8 Global Dual Chamber Prefilled Syringes Market, By Material

  • 8.1 Introduction
  • 8.2 Glass
  • 8.3 Plastic
  • 8.4 Other Materials

9 Global Dual Chamber Prefilled Syringes Market, By Distribution Channel

  • 9.1 Introduction
  • 9.2 Hospitals Pharmacies
  • 9.3 Retail Pharmacies
  • 9.4 Online Pharmacies

10 Global Dual Chamber Prefilled Syringes Market, By Application

  • 10.1 Introduction
  • 10.2 Liquid/Powder
  • 10.3 Liquid/Liquid
  • 10.4 Liquid/Lyophilisate
  • 10.5 Other Applications

11 Global Dual Chamber Prefilled Syringes Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Gerresheimer AG
  • 13.2 Medtronic
  • 13.3 Bayer AG
  • 13.4 Nipro Corporation
  • 13.5 Elcam Drug Delivery Devices
  • 13.6 Pfizer Inc.
  • 13.7 Novartis AG
  • 13.8 AbbVie Inc.
  • 13.9 Mylan N.V.
  • 13.10 Otsuka America Pharmaceutical, Inc.
  • 13.11 Credence MedSystems Inc.
  • 13.12 Vetter Pharma-Fertigung GmbH & Co. KG
  • 13.13 Maeda Industry Co. Ltd.
  • 13.14 Catalent, Inc.
  • 13.15 Terumo Europe NV
  • 13.16 West Pharmaceutical Services, Inc.
  • 13.17 Schott AG

List of Tables

  • Table 1 Global Dual Chamber Prefilled Syringes Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Dual Chamber Prefilled Syringes Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Dual Chamber Prefilled Syringes Market Outlook, By Conventional Prefilled Syringes (2021-2030) ($MN)
  • Table 4 Global Dual Chamber Prefilled Syringes Market Outlook, By Safety Prefilled Syringes (2021-2030) ($MN)
  • Table 5 Global Dual Chamber Prefilled Syringes Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 6 Global Dual Chamber Prefilled Syringes Market Outlook, By Type (2021-2030) ($MN)
  • Table 7 Global Dual Chamber Prefilled Syringes Market Outlook, By <1 ml (2021-2030) ($MN)
  • Table 8 Global Dual Chamber Prefilled Syringes Market Outlook, By 1 ml-2.5 ml (2021-2030) ($MN)
  • Table 9 Global Dual Chamber Prefilled Syringes Market Outlook, By 2.5 ml-5.0 ml (2021-2030) ($MN)
  • Table 10 Global Dual Chamber Prefilled Syringes Market Outlook, By >5.0 ml (2021-2030) ($MN)
  • Table 11 Global Dual Chamber Prefilled Syringes Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 12 Global Dual Chamber Prefilled Syringes Market Outlook, By Indication (2021-2030) ($MN)
  • Table 13 Global Dual Chamber Prefilled Syringes Market Outlook, By Hemophilia (2021-2030) ($MN)
  • Table 14 Global Dual Chamber Prefilled Syringes Market Outlook, By Schizophrenia (2021-2030) ($MN)
  • Table 15 Global Dual Chamber Prefilled Syringes Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 16 Global Dual Chamber Prefilled Syringes Market Outlook, By Erectile Dysfunction (2021-2030) ($MN)
  • Table 17 Global Dual Chamber Prefilled Syringes Market Outlook, By Endometriosis (2021-2030) ($MN)
  • Table 18 Global Dual Chamber Prefilled Syringes Market Outlook, By Other Indications (2021-2030) ($MN)
  • Table 19 Global Dual Chamber Prefilled Syringes Market Outlook, By Material (2021-2030) ($MN)
  • Table 20 Global Dual Chamber Prefilled Syringes Market Outlook, By Glass (2021-2030) ($MN)
  • Table 21 Global Dual Chamber Prefilled Syringes Market Outlook, By Plastic (2021-2030) ($MN)
  • Table 22 Global Dual Chamber Prefilled Syringes Market Outlook, By Other Materials (2021-2030) ($MN)
  • Table 23 Global Dual Chamber Prefilled Syringes Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 24 Global Dual Chamber Prefilled Syringes Market Outlook, By Hospitals Pharmacies (2021-2030) ($MN)
  • Table 25 Global Dual Chamber Prefilled Syringes Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 26 Global Dual Chamber Prefilled Syringes Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 27 Global Dual Chamber Prefilled Syringes Market Outlook, By Application (2021-2030) ($MN)
  • Table 28 Global Dual Chamber Prefilled Syringes Market Outlook, By Liquid/Powder (2021-2030) ($MN)
  • Table 29 Global Dual Chamber Prefilled Syringes Market Outlook, By Liquid/Liquid (2021-2030) ($MN)
  • Table 30 Global Dual Chamber Prefilled Syringes Market Outlook, By Liquid/Lyophilisate (2021-2030) ($MN)
  • Table 31 Global Dual Chamber Prefilled Syringes Market Outlook, By Other Applications (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.